NCT03984370View on ClinicalTrials.gov

Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

February 26, 2020

Study Completion Date

February 26, 2020

Conditions
Hyperinsulinemic HypoglycemiaPostprandial Hypoglycemia
Interventions
DRUG

ZP4207

Abdominal SC administration

OTHER

Placebo (saline)

Abdominal SC administration

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Herlev-Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03984370 - Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass | Biotech Hunter | Biotech Hunter